cas 58479-61-1||tert-butyl-chloro-diphenylsilane

Nombre del producto:tert-butyl-chloro-diphenylsilane

IUPAC Name:tert-butyl(chloro)diphenylsilane

Unidad de embalaje	Stock disponible	Precio($)
CM328470-500g	in stock	ƏƴŁ
CM328470-1000g	in stock	ţŁţ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 58479-61-1 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :58479-61-1; Fórmula molecular:C16H19ClSi; Punto de fusión:-; Código de sonrisas:Cl[Si](C1=CC=CC=C1)(C(C)(C)C)C2=CC=CC=C2; Densidad:

: Número de catálogo:CM328470; Peso molecular:274.86; Punto de ebullición:; Nº Mdl:; Almacenamiento:

: Namodenoson; Namodenoson is a small orally bioavailable drug that binds with high affinity and selectivity to the A3 adenosine receptor (A3AR). Namodenoson was evaluated in Phase II trials for two indications, as a second line treatment for hepatocellular carcinoma, and as a treatment for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
Namodenoson granted Orphan Drug and Fast track status from the FDA. A3AR is highly expressed in diseased cells whereas low expression is found in normal cells. This differential effect accounts for the excellent safety profile of the drug.